Pancreatic Cancer Research

ResearcherRoyal Surrey County HospitalActive in the last 2 years

Nabeel Merali

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9030-8073; OpenAlex author ID A5004886920. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2022: 1 paper · 2023: 4 papers · 2024: 4 papers · 2025: none · 2026: 2 papers

Papers 11

  1. Colonization of bile with gammaproteobacteria is associated with reduced survival after surgery for pancreatic cancer in patients receiving gemcitabine-based a… Co-author DOI 10.1016/j.ejso.2026.111396↗
  2. Coordinated immune architecture underlies durable survival in pancreatic cancer Co-author DOI 10.64898/2026.04.29.721612↗
  3. Impact of tertiary lymphoid structures on prognosis and therapeutic response in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2024.04.009↗
  4. What are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer? Co-author DOI 10.1080/17474124.2024.2351398↗
  5. Implications of the microbiome after pancreatic cancer resection with regard to morbidity and mortality. Co-author DOI 10.1080/17474124.2024.2427648↗
  6. The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing. Co-author DOI 10.1097/js9.0000000000001762↗
  7. Graphene Sensor Arrays for Rapid and Accurate Detection of Pancreatic Cancer Exosomes in Patients' Blood Plasma Samples. Co-author DOI 10.1021/acsnano.3c01812↗
  8. Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers15174265↗
  9. Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and Therapies? Co-author DOI 10.3390/cancers15215140↗
  10. Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study. Co-author DOI 10.3390/ijms242316888↗
  11. A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14041020↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Adam Enver Frampton · 11 shared papers, 2022–2026 · strength 2.12
  2. Nicola E. Annels · 7 shared papers, 2022–2026 · strength 1.29
  3. Tarak Agrebi Moumni Chouari · 7 shared papers, 2022–2026 · strength 1.29
  4. Shivan Sivakumar · 5 shared papers, 2023–2026 · strength 0.92
  5. Elisa Giovannetti · 5 shared papers, 2022–2026 · strength 0.90
  6. Keith John Roberts · 4 shared papers, 2023–2026 · strength 0.78
  7. Lewis A Hall · 2 shared papers, 2023–2026 · strength 0.47
  8. James Michael Halle-Smith · 2 shared papers, 2023–2024 · strength 0.36
  9. Eirini G. Velliou · 2 shared papers, 2023–2024 · strength 0.31
  10. Daniel Liu · 2 shared papers, 2023 · strength 0.28
  11. Charlotte Terry · 1 shared paper, 2026 · strength 0.28
  12. David Christopher Bartlett · 1 shared paper, 2026 · strength 0.28
  13. Robert Peter Sutcliffe · 1 shared paper, 2026 · strength 0.28
  14. Nikolaos A. Chatzizacharias · 1 shared paper, 2026 · strength 0.28
  15. S.S. Raza · 1 shared paper, 2026 · strength 0.28
  16. Jonathan Krell · 2 shared papers, 2022–2023 · strength 0.28
  17. Michele Ammendola · 1 shared paper, 2024 · strength 0.22
  18. Francesca Vescio · 1 shared paper, 2024 · strength 0.22
  19. Irena Stefanova · 1 shared paper, 2024 · strength 0.22
  20. Anguraj Sadanandam · 1 shared paper, 2026 · strength 0.21
  21. Rachael J. M. Bashford-Rogers · 1 shared paper, 2026 · strength 0.21
  22. Michael Loran Dustin · 1 shared paper, 2026 · strength 0.21
  23. Shihong Wu · 1 shared paper, 2026 · strength 0.21
  24. Alex Nicolas Gordon-Weeks · 1 shared paper, 2026 · strength 0.21
  25. Paul A. H. Moss · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.